Clinical Trial Update: PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a PD-1 inhibitor in patients with advanced basal cell carcinoma who progressed on Hedgehog pathway inhibitors or were intolerant to pri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Cemiplimab (cemiplimab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Carcinoma, Basal Cell | Phase 2 | Status: COMPLETED | Results posted: 2022-07-26